AI-enhanced breast MRI with a 75% reduced gadolinium dose maintained diagnostic sensitivity comparable to full-dose protocols.
Key Details
- 1Single-center study with 20 female participants having biopsy-proven malignancies or high-risk indications.
- 2Low-dose (0.025 mmol/kg) MRI scans with AI were compared to standard-dose (0.1 mmol/kg) with/without AI.
- 3Diagnostic sensitivity with low-dose + AI was 83.3% (p=1 vs. standard), accuracy was 74.5% vs. 69.5% (standard) and 65.5% (standard+AI).
- 498 lesions detected; 12 were biopsy-proven malignancies; high NPVs (93-94%) across all protocols.
- 5AI-assisted low-dose MRI had the highest PPV (50%) and substantial interreader agreement (kappa 0.65-0.74).
- 6Study was small and lacked long-term outcome data; funded by Bracco.
Why It Matters
Gadolinium retention and cost are growing concerns in breast imaging. This study shows that AI-powered image enhancement could allow safer, lower-dose protocols without compromising cancer detection, marking a significant step for both patient safety and clinical feasibility.
Source
AuntMinnie
Related News
•HealthExec
New Report Highlights Clinical AI Performance, Sustainability, and Adoption Challenges
A multi-institutional review details key challenges, progress, and sustainability concerns in deploying clinical AI in real-world healthcare settings.
•AuntMinnie
LLM Boosts Terminology Expansion in Radiology Reports Over RadLex
A large language model (LLM) significantly outperforms RadLex in expanding terms for radiology report language standardization.
•Radiology Business
Google Releases MedGemma 1.5 and MedASR AI Models for Medical Imaging
Google has launched MedGemma 1.5 and MedASR, two new open-access AI models tailored for healthcare and medical imaging use cases.